Pro-life group calls FDA’s approval of generic abortion pill ‘unconscionable’

Pro-life group calls FDA’s approval of generic abortion pill ‘unconscionable’

Spread the love

A pro-life organization called the FDA’s approval of the generic version of the abortion drug mifepristone “unconscionable,” stating that abortion is the leading cause of death in the nation, that the abortion pill undermines states’ rights, and that approval for the drug should be pulled.

Political Communications Director for Susan B. Anthony Pro-Life America Kelsey Pritchard told The Center Square that “the FDA approving another cheap abortion drug, when countless babies are being killed and women sent to the ER, is unconscionable.”

Susan B. Anthony Pro-Life America is a nonprofit with a mission to “end abortion by electing national leaders and advocating for laws that save lives,” as stated on its website.

Kelsey Pritchard told The Center Square: “With at least 1.1 million abortions a year, more than 60% of which are caused by abortion drugs, it is the nation’s top cause of death.”

“Nothing about this makes America great or healthy,” Pritchard said, playing off the “Make America Great Again” and “Healthy Again” slogans.

Pritchard told The Center Square that “a mounting body of evidence shows these drugs are unsafe for women, with alarming rates of complications like hemorrhage, infection and need for surgery.”

“Generic drugs aren’t required to have independent data on their safety and effectiveness, so we assume this one has all the same problems as the original,” Pritchard said.

When reached, HHS Communications Director Andrew Nixon told The Center Square that “the FDA has very limited discretion in deciding whether to approve a generic drug.”

“By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is identical to the brand-name drug,” Nixon said.

Like Pritchard, Nixon said that “generic applicants are not required to submit independent evidence proving safety and effectiveness.”

“The FDA does not endorse any drug product and directs prescribers to follow all labeling,” Nixon said.

“HHS is conducting a study of the reported adverse effects of mifepristone to ensure the FDA’s risk mitigation program for the drug is sufficient to protect women from unstated risks,” Nixon said.

Pritchard acknowledged to The Center Square that “Secretary Kennedy and Commissioner Makary promised to review fresh data on mifepristone’s dangers,” but noted that “nothing stops them from immediately reinstating safety standards that were in place during President Trump’s first term.”

Pritchard said the abortion drug mifepristone was originally fast-tracked for approval under President Bill Clinton by classifying pregnancy as an illness.”

“The Biden administration made things even worse by burying safety signals – as HHS Secretary Robert F. Kennedy himself revealed last month – and stripping away guardrails like in-person doctor visits, making deadly mail-order drugs the rule nationwide and undermining pro-life states’ heroic efforts to enforce their laws,” Pritchard said.

“Because they are easily obtained over the web, and pro-abortion Democrats like Gavin Newsom are legalizing totally anonymous prescription, they are increasingly used to coerce and poison women who never even sought abortions,” Pritchard said.

“Ultimately, approval for all abortion drugs should be pulled,” Pritchard told The Center Square.

Leave a Comment





Latest News Stories

U.S. House vote on spy powers extension delayed due to bipartisan pushback

U.S. House vote on spy powers extension delayed due to bipartisan pushback

By Thérèse BoudreauxThe Center Square U.S. House Speaker Mike Johnson, R-La., is postponing a vote on a clean extension of the federal government’s electronic surveillance powers due to member pushback....
Auditors praise Trump anti-fraud healthcare proposal

Auditors praise Trump anti-fraud healthcare proposal

By Andrew RiceThe Center Square A coalition of 14 state financial leaders across the country backed a Trump administration policy to reduce fraud in health-care systems. The group of state...

WATCH: Gun owners rally at Illinois Statehouse against more gun regulations

By Greg Bishop | The Center SquareThe Center Square (The Center Square) – Illinois gun owners are pressing their legislators to oppose gun regulations and some elected officials are on...
GOP seeks probe of $180B in fraud with taxpayers' money

GOP seeks probe of $180B in fraud with taxpayers’ money

By Madeline ShannonThe Center Square California’s Assembly Republican Caucus on Wednesday called for a special legislative session to investigate an estimated $180 billion in fraud in taxpayer-funded programs. “Fraud absolutely...
Bill advances to prevent local governments from clearing homeless camps

Bill advances to prevent local governments from clearing homeless camps

By Jim Talamonti | The Center SquareThe Center Square (The Center Square) – State law may soon restrict local governments from clearing homeless encampments from parks and other public spaces....
Bonta’s anti-Exxon emails may have run afoul of CA corruption law: Claim

Bonta’s anti-Exxon emails may have run afoul of CA corruption law: Claim

By Michael Carroll | Legal NewslineThe Center Square A Texas federal judge’s decision to allow ExxonMobil’s defamation lawsuit against California Attorney General Rob Bonta to move forward could ensnare Bonta...
Expulsion votes for two members of Congress could happen next week, Luna says

Expulsion votes for two members of Congress could happen next week, Luna says

By Bethany BlankleyThe Center Square Two more members of Congress may be forced to resign next week or face votes for their expulsion, U.S. Rep. Anna Paulina Luna, R-Florida, says....
NAACP sues xAI over air pollution near Memphis data center

NAACP sues xAI over air pollution near Memphis data center

By Alton WallaceThe Center Square The NAACP filed a lawsuit in federal court Tuesday against Elon Musk’s xAI, saying the company is illegally operating 27 methane gas turbines in Mississippi...
Trump says he's ready to nominate up to three Supreme Court justices

Trump says he’s ready to nominate up to three Supreme Court justices

By Brett RowlandThe Center Square President Donald Trump said Wednesday he is "prepared" to nominate another Supreme Court justice to the bench, should a vacancy arise. No justice has publicly...
Military hostilities in Iran continue after Senate tanks War Powers Resolution

Military hostilities in Iran continue after Senate tanks War Powers Resolution

By Thérèse BoudreauxThe Center Square For the second time in the U.S. Senate, Republicans tanked a War Powers Resolution that would have halted the ongoing U.S. military operations in Iran....

WATCH: Detransitioner battles to revive landmark malpractice and fraud lawsuit

By Carleen JohnsonThe Center Square A woman at the center of the detransition movement is waiting to find out if a North Carolina appeals court will let her case proceed...
Iran economic fallout is temporary, Hassett says

Iran economic fallout is temporary, Hassett says

By Andrew RiceThe Center Square The economic fallout of the U.S. conflict in Iran will be temporary, National Economic Council Director Kevin Hassett said on Wednesday. Hassett touted the Trump...
Illinois Quick Hits: NFIB says biz deduction will bring jobs, benefit to Illinois

Illinois Quick Hits: NFIB says biz deduction will bring jobs, benefit to Illinois

By Jim Talamonti | The Center SquareThe Center Square (The Center Square) – The National Federation of Independent Business says Illinois is projected to gain 48,000 new jobs each year...
Soaring costs and short supply shut millennials out of housing market

Soaring costs and short supply shut millennials out of housing market

By Brett RowlandThe Center Square Baby Boomers continue to dominate the U.S. housing market, buying and selling more homes last year than any other generation, while homeownership remains out of...
Vought testifies before lawmakers on Trump's $2.1T budget request

Vought testifies before lawmakers on Trump’s $2.1T budget request

By Thérèse BoudreauxThe Center Square Office of Management and Budget Director Russ Vought met with U.S. lawmakers Wednesday to discuss the president’s $2.1 trillion budget proposal for the next fiscal...